| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,168 | 28,755 | 30,447 | 30,894 | | Cost of Revenue | 7,317 | 8,102 | 8,980 | 9,559 | | | Gross Profit | 19,851 | 20,653 | 21,467 | 21,335 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,862 | 11,133 | 14,481 | 16,312 | | Non Recurring | (10,131) | 10,131 |
-
| 27,634 | | Others | 21,580 | 20,630 | 10,530 | 13,850 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (17,460) | (21,241) | (3,544) | (36,461) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (17,460) | (21,241) | (3,544) | (36,461) | | Interest Expense | 3,023 | 3,031 | 3,348 | 3,876 | | Income Before Tax | (20,483) | (24,272) | (6,892) | (40,337) | | Income Tax Expense | (598) | 6,134 | (2,750) | (5,280) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,885) | (30,406) | (4,142) | (35,057) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,885) | (30,406) | (4,142) | (35,057) | | Preferred Stock And Other Adjustments | (991) | (939) | (939) | (817) | | | Net Income Applicable To Common Shares | ($20,876) | ($31,345) | ($5,081) | ($35,874) |
|
0.31% Nasdaq 
0.05%
Income Statement
